MedPath

Spironolactone

These highlights do not include all the information needed to use SPIRONOLACTONE TABLETS safely and effectively. See full prescribing information for SPIRONOLACTONE TABLETS. SPIRONOLACTONE (spironolactone) tablets for oral use Initial U.S. Approval: 1960

Approved
Approval ID

a15cf499-6e46-d829-e053-2995a90abd01

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 3, 2020

Manufacturers
FDA

Denton Pharma, Inc. DBA Northwind Pharmaceuticals

DUNS: 080355546

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

spironolactone

PRODUCT DETAILS

NDC Product Code70934-368
Application NumberANDA203512
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJune 3, 2020
Generic Namespironolactone

INGREDIENTS (14)

POVIDONE K25Inactive
Code: K0KQV10C35
Classification: IACT
PEPPERMINT OILInactive
Code: AV092KU4JH
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
SPIRONOLACTONEActive
Quantity: 50 mg in 1 1
Code: 27O7W4T232
Classification: ACTIB
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
DIBASIC CALCIUM PHOSPHATE DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Spironolactone - FDA Drug Approval Details